The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
115882074 11588207 4 F 20150831 20160324 20151002 20160401 EXP JP-009507513-1509JPN014101 MERCK 67.00 YR M Y 43.00000 KG 20160401 CN CH JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
115882074 11588207 1 PS CUBICIN DAPTOMYCIN 1 Intravenous drip 245 MG, QD 980 MG 21572 245 MG INJECTION QD
115882074 11588207 2 SS CUBICIN DAPTOMYCIN 1 980 MG 21572 INJECTION
115882074 11588207 3 SS TEICOPLANIN TEICOPLANIN 1 Intravenous (not otherwise specified) 400 MG, BID 11200 MG 0 400 MG INJECTION BID
115882074 11588207 4 SS TEICOPLANIN TEICOPLANIN 1 11200 MG 0 INJECTION
115882074 11588207 5 C OMEPRAL OMEPRAZOLE 1 Unknown 20 MG, BID U 0 20 MG BID
115882074 11588207 6 C AMBISOME AMPHOTERICIN B 1 Intravenous (not otherwise specified) 100 MG, QD 800 MG U 0 100 MG INJECTION QD
115882074 11588207 7 C AMBISOME AMPHOTERICIN B 1 800 MG U 0 INJECTION
115882074 11588207 8 C VANCOMYCIN HYDROCHLORIDE. VANCOMYCIN HYDROCHLORIDE 1 Intravenous (not otherwise specified) 500 MG, BID 3000 MG U 0 500 MG INJECTION BID
115882074 11588207 9 C VANCOMYCIN HYDROCHLORIDE. VANCOMYCIN HYDROCHLORIDE 1 UNK 3000 MG U 0 INJECTION
115882074 11588207 10 C NEOPAREN AMINO ACIDSDEXTROSEELECTROLYTES NOS 1 Intravenous (not otherwise specified) 2000 ML, QD U 0 INJECTION QD
115882074 11588207 11 C PANTHENOL PANTHENOL 1 Intravenous (not otherwise specified) 500 MG, BID 29000 MG U 0 500 MG INJECTION BID
115882074 11588207 12 C ASPARA POTASSIUM POTASSIUM ASPARTATE 1 Intravenous (not otherwise specified) 10 ME, BID, MIXED WITH NEOPAREN U 0 INJECTION BID
115882074 11588207 13 C DAI-KENCHU-TO MALTOSE 1 Other 2.5 G, TID, ROUTE OF ADMINISTRATION: GASTRIC FISTULA 330 G U 0 2.5 G GRANULES TID
115882074 11588207 14 C YOKU-KAN-SAN 2 Other 2.5 MG, TID, ROUTE OF ADMINISTRATION: GASTRIC FISTULA 330 MG U 0 2.5 MG GRANULES TID
115882074 11588207 15 C GASCON (dimethicone) DIMETHICONE 1 Other 40 MG, TID, ROUTE OF ADMINISTRATION: GASTRIC FISTULA 5280 MG U 0 40 MG TABLET TID
115882074 11588207 16 C LANSOPRAZOLE. LANSOPRAZOLE 1 Other 15 MG, QD, ROUTE OF ADMINISTRATION: GASTRIC FISTULA 660 MG U 0 15 MG TABLET QD
115882074 11588207 17 C TANATRIL IMIDAPRIL 1 Other 5 MG, QD, ROUTE OF ADMINISTRATION: GASTRIC FISTULA 220 MG U 0 5 MG TABLET QD
115882074 11588207 18 C CARBOCYSTEINE CARBOCYSTEINE 1 Other 500 MG, TID, ROUTE OF ADMINISTRATION: GASTRIC FISTULA 66000 MG U 0 500 MG SYRUP TID
115882074 11588207 19 C MUCOBULIN AMBROXOL HYDROCHLORIDE 1 Other 45 MG, TID, ROUTE OF ADMINISTRATION: GASTRIC FISTULA 5940 MG U 0 45 MG TABLET TID
115882074 11588207 20 C NEOPHAGEN INJECTION 2 Intravenous (not otherwise specified) 40 MG, BID 2320 MG U 0 40 MG INJECTION BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
115882074 11588207 1 Pneumonia
115882074 11588207 2 Device related infection
115882074 11588207 3 Pneumonia
115882074 11588207 4 Device related infection
115882074 11588207 6 Pneumonia
115882074 11588207 7 Device related infection
115882074 11588207 8 Pneumonia
115882074 11588207 9 Device related infection
115882074 11588207 10 Electrolyte substitution therapy
115882074 11588207 11 Vitamin supplementation
115882074 11588207 12 Electrolyte substitution therapy

Outcome of event

Event ID CASEID OUTC COD
115882074 11588207 OT
115882074 11588207 HO
115882074 11588207 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
115882074 11588207 Hepatic function abnormal
115882074 11588207 Pneumonia
115882074 11588207 Staphylococcal sepsis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
115882074 11588207 1 20150829 20150901 0
115882074 11588207 3 20150902 20150915 0
115882074 11588207 6 20150824 20150831 0
115882074 11588207 8 20150827 20150829 0
115882074 11588207 9 20150808 0
115882074 11588207 10 20150828 20150925 0
115882074 11588207 11 20150828 20150925 0
115882074 11588207 12 20150823 20150925 0
115882074 11588207 13 20150813 20150925 0
115882074 11588207 14 20150813 20150925 0
115882074 11588207 15 20150813 20150925 0
115882074 11588207 16 20150813 20150925 0
115882074 11588207 17 20150813 20150925 0
115882074 11588207 18 20150813 20150925 0
115882074 11588207 19 20150813 20150925 0
115882074 11588207 20 20150828 20150925 0